1887

Chapter 1 : Historical Review of Antibacterial Chemotherapy

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Historical Review of Antibacterial Chemotherapy, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815929/9781555812379_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555815929/9781555812379_Chap01-2.gif

Abstract:

Apart from a few parasitic diseases, the antibacterial chemotherapy developed by Paul Ehrlich at the end of the 19th century was limited purely to the treatment of syphilis. From 1945, research in the field of antibacterial chemotherapy followed two directions: (i) synthetic antibacterial agents not found in nature and (ii) antibiotics extracted from the fermentation of molds, actinomycetes, and other bacterial genera. In 1929, Fleming published his studies on the potent antibacterial activity of a very active substance known as penicillin, which was capable of inhibiting the growth of and and that was also practically devoid of toxicity. In the mid-1970s, the bacterial ecology of hospitals changed and the focus of concerns in anti-infective therapy moved towards and certain species of , particularly spp. Research into β-lactams was conducted simultaneously in the fields of penicillins and cephems. The major characteristic of these molecules is their good activity against cephalosporinase-producing strains of enterobacteria. In 1907, Charles Nicolle noted that was capable of lysing pneumococci. Later, E. Duclaux discovered the same property in other species. Future research into antibacterial chemotherapy should consider not only the potential antibacterial activity of the new derivatives but also their immunological properties.

Citation: Bryskier A. 2005. Historical Review of Antibacterial Chemotherapy, p 1-12. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch1

Key Concept Ranking

Antibacterial Agents
1.6292984
Chemicals
0.7938586
Glycopeptide Antibiotics
0.70048577
Bacteria
0.68218386
Vaccines
0.66881377
1.6292984
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815929.ch01
1. Acar JF,, Bryskier A, 1994, Histoire et développement des céphalosporines, Lettre de l’Infectiologue, suppl (maîtrise des infections hospitalières, place de Cefrom®), p 47.
2. Bergogne-Bérézin E, 1993, Le siècle de la microbiologie, Presse Med, 22, 15431552.
3. Boggiano BG,, Gleeson M, 1976, Gastric inactivation of erythromycin stearate in solid dosage forms, J Pharm Sci 65, 497502.
4. Bryskier A, 1995, L’antibiothérapie au passé, au presént et au futur, Presse Med, 24, 5565.
5. Bryskier A, 1996, Historique, classification et perspectives de développement des antibiotiques et des agents antibactériens, Med Ther, suppl, 718.
6. Bryskier A, 1997, Histoire et renouveau des macrolides, Presse Med, 26, 10631069.
7. Bryskier A, 2003, Paul Gehrard Domagk, le découvreur des sulfamides, Chemother J, 12, 97105, in German.
8. Bryskier A,, Chantot JF,, Labro MT,, Gasc J-C, 1989, Evolution et tendance moderne de l’antibiothérapie, in Zribi A,, Bryskier A, ed, l’Antibiothérapie d’aujourd’hui et de demain, Arnette, Paris, p 1129.
9. Fleming A, 1946, Penicillin, Its Practical Application, Butterworth & Co Ltd, London, p 380.
10. Goldberg HS,, Luckey TD, 1955, Introduction, in Goldberg HS, ed, Antibiotics, Their Chemistry and Non-Medical Uses, D. Van Nostrand Co. Inc., Princeton, NJ, p 18.
11. Jukes TH, 1985, Some historical notes on chlortetracyclines, Rev Infect Dis, 5, 702707.
12. Lapresle C, 1986, Les sulfamides en médecine, Bull Inst Pasteur, 84, 181188.
13. Lepper MH, 1956, Aureomycin (chlortetracycline), monograph 7, p 156, Medical Encyclopedia, New York.
14. Levaditi C,, Vaisman A,, Henry-Eveno J,, Veillet J,, Sandor T, 1952, Le chloramphénicol (chloromycetine) et ses applications therapeutiques, Bailleres JB et fils, Paris, p 171.
15. Parascandola J, 1980, The history of antibiotics, a symposium, American Institute of the History of Pharmacy, Madison, Wis, 137 p.
16. Rolison GN, 1988, From Pasteur to penicillin. The history of antibacterial chemotherapy, Zbl Bakt Hyg A 267, 207315.
17. Umezawa H,, Ueda M,, Maeda K,, Yagishita K,, Kondo S,, Okami Y,, Utahara R,, Osato Y,, Nitta K,, Takeuchi T, 1957, Production and isolation of a new antibiotic: kanamycin, J Antibiot (Tokyo), 10, 181188.
18. Waksman SA, 1949, Streptomycin, Nature and Practical Application, The Williams & Wilkins Co, Baltimore, p 618.
19. Waksman SA, 1958, Neomycin, Its Nature and Practical Application, The Williams & Wilkins Co, Baltimore, p 412.
20. Waksman SA, 1968, Actinomycin, Nature, Formation, and Activities, Intersciences Publ, John Wiley & Sons Inc, New York, p 231.
21. Weinstein L,, Ehrenkrantz NJ, 1958, Streptomycin and dihydrostreptomycin, monograph 10, p 116, Medical Encyclopedia, New York.
22. Woodward TE,, Wisseman L, Jr, 1958, Chloromycetin (chloramphenicol), Antibiotics monograph 8, p 159, Medical Encyclopedia, New York.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error